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Abstract
Background: There is increasing debate about whether the scaled-up investment in HIV/AIDS
programs is strengthening or weakening the fragile health systems of many developing countries.
This article examines and assesses the evidence and proposes ways forward.
Discussion: Considerably increased resources have been brought into countries for HIV/AIDS
programs by major Global Health Initiatives. Among the positive impacts are the increased
awareness of and priority given to public health by governments. In addition, services to people
living with HIV/AIDS have rapidly expanded. In many countries infrastructure and laboratories have
been strengthened, and in some, primary health care services have been improved. The effect of
AIDS on the health work force has been lessened by the provision of antiretroviral treatment to
HIV-infected health care workers, by training, and, to an extent, by task-shifting. However, there
are reports of concerns, too – among them, a temporal association between increasing AIDS
funding and stagnant reproductive health funding, and accusations that scarce personnel are
siphoned off from other health care services by offers of better-paying jobs in HIV/AIDS programs.
Unfortunately, there is limited hard evidence of these health system impacts.
Because service delivery for AIDS has not yet reached a level that could conceivably be considered
"as close to Universal Access as possible," countries and development partners must maintain the
momentum of investment in HIV/AIDS programs. At the same time, it should be recognized that
global action for health is even more underfunded than is the response to the HIV epidemic. The
real issue is therefore not whether to fund AIDS or health systems, but how to increase funding
for both.
Summary: The evidence is mixed – mostly positive but some negative – as to the impact on health
systems of the scaled-up responses to HIV/AIDS driven primarily by global health partnerships.
Current scaled-up responses to HIV/AIDS must be maintained and strengthened. Instead of endless
debate about the comparative advantages of vertical and horizontal approaches, partners should
focus on the best ways for investments in response to HIV to also broadly strengthen the primary
health care systems.
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Background
In the past several years, countries have geared up their
response to HIV/AIDS, supported by global health initia-
tives/partnerships (GHIs) such as the Global Fund to
Fight AIDS, Tuberculosis and Malaria (GFATM); the
United States President Emergency Plan for AIDS Relief
(PEPFAR); the World Bank Multi-Country AIDS Program
(MAP); and bilateral donors [1]. Others – such as the
World Health Organization (WHO), cosponsors of the
Joint United Nations Program on HIV/AIDS (UNAIDS),
private foundations such as the Gates and Clinton Foun-
dations, and nongovernmental organizations such as
Médecins Sans Frontières (MSF, Doctors without Borders)
– provide additional support.
These contributions have led to unprecedented attention
for AIDS as a health issue, and have enabled many people
living with HIV/AIDS (PLWHA) to survive and sustain
their families. However, the introduction of antiretroviral
(ARV) treatment, along with other interventions that the
health sector has made, also exposed the effects of decades
of neglect of the health sector, economic crises, structural
adjustments, declining public expenditures, and decen-
tralized financing, particularly in Sub-Saharan Africa [2].
This is one reason for the recent revival of the long-stand-
ing debate on whether scaling up the responses to specific
health problems in developing countries, especially HIV/
AIDS, is strengthening or weakening their stretched and
fragmented health systems [3-8].
In this paper we examine the case for and against funding
AIDS as a specific health issue, and suggest ways to
increase the potential for HIV/AIDS funding and pro-
grams to deliver further on the promise of health systems
development. We first examine the effects of HIV/AIDS
itself on health systems, and then enumerate the effects of
HIV/AIDS programs on health-system building blocks, by
searching and reviewing the available literatures pub-
lished and available in the public domain using PubMed,
POPLINE®, AEGiS (AIDS Education Global Information
System), Google Scholar™ and other databases. We use
the 2007 WHO definition of a health system as "all organ-
izations, people and actions whose primary intent is to pro-
mote, restore or maintain health," and also use WHO's
description of six health-system building blocks: (1) effec-
tive, safe, and high-quality health services, (2) a respon-
sive health work force, (3) a well-functioning health
information system, (4) equitable access to essential med-
ical products, vaccines, and technologies, (5) a good
health-financing system, and (6) strong leadership and
governance [9].
Results
The effect of HIV/AIDS itself on health systems
In the face of increased pressure caused by untreated HIV/
AIDS sufferers seeking health care, resulting in opportun-
istic infections, it was obvious that in many places health
systems were increasingly unable to provide even the
most basic levels of preventive and curative care: infant
and maternal mortality increased, and decades of public
health gains were lost in countries with a high burden of
HIV/AIDS [10].
HIV/AIDS increases the demand for health services, and at
the same time it reduces the ability of the health service to
supply them. Prior to the advent of ARV therapy, half of
all medical hospital beds in Sub-Saharan Africa were occu-
pied by people with AIDS. In some countries of East
Africa, this proportion reached 80 percent [11]. The effect
was that patients with HIV infection crowded out people
with other conditions [12,13]. The presence of a large
number of AIDS patients with very poor outlooks also
contributed to the health professions losing their attrac-
tiveness because of increased workloads, exposure to HIV
infection, and the work stress that resulted from it [12].
In addition, the ability of the health service to cope with
this increased demand declined, because of HIV-related
morbidity and mortality and burnout among health pro-
fessionals. For example, five-to-sixfold increases in health
worker illness and death rates were reported for Malawi,
and the number of deaths of nurses there represented 40
percent of the average annual output of nurses from train-
ing [14].
The impact of HIV/AIDS programs on health systems
Access to antiretroviral treatment (ART) and other HIV-
related services in the health sector likely has both positive
and negative effects on the supply of and demand for
health services. On the one hand, it is known from indus-
trialized countries and Brazil that patient demand for hos-
pitalization and diagnostic evaluation for opportunistic
diseases decreased following the introduction of ART
[15,16]. In those settings, this also resulted in savings in
health sector expenditures. On the other hand, where
health care is less sophisticated and less costly, this is
might be offset by the need to provide long-term outpa-
tient care to more and more people requiring lifelong
treatment and laboratory tests to monitor ART [17], and
scaled-up some HIV prevention interventions, such as
male circumcision and prevention of mother-to-child
transmission (PMTCT). To date, despite claims that
investing in HIV decreases the ability of the health system
to produce other health outcomes, the evidence that this
is actually happening is largely anecdotal and equivocal
[3,7], with as many pointers confirming as arguing against
this stance [18,19].Globalization and Health 2008, 4:8 http://www.globalizationandhealth.com/content/4/1/8
Page 3 of 10
(page number not for citation purposes)
Has health service delivery been expanded?
In all countries, HIV/AIDS programs have dramatically
improved the delivery of prevention and care services to
people living with HIV/AIDS (PLWHA). Although the
scaling up of HIV services has likely not escaped the bias
of health systems in general to better serve urban and
more affluent groups, considerable efforts have been
made to overcome equity concerns and reach the most
vulnerable, marginalized groups, such as injecting drug
users (IDUs), sex workers, and men who have sex with
men (MSM) [20-24].
The most spectacular result of WHO's "3 by 5" initiative
was to demonstrate that delivering ART through a public
health approach is feasible even where health systems are
weak overall [25]. Worldwide, around 3 million PLWHA
are currently on ART [26]. As effective HIV treatment pro-
grams are implemented, hospital admissions plummet
and hospital beds are freed up, easing the burden on
health care staff throughout the system [27-29]. With the
success of the public health model of service delivery and
the demonstrable adherence of patients on treatment
across the world, and especially in Africa, treatment for
AIDS is saving and changing lives [30]. In Brazil, where
free ARV treatment has been made available through the
national health services since 1996, historical evaluation
suggests that the country's ART program led to a 40 to 70
percent decrease in mortality, a 60 to 80 percent decrease
in morbidity, an 85 percent decrease in hospitalization
[31], and savings of US$ 1.2 billion in health care costs
[32].
Equally important, HIV/AIDS prevention and treatment
programs in some places have helped to reinvigorate
efforts to promote primary health care (PHC) by provid-
ing services such as childhood vaccinations, family plan-
ning, tuberculosis case-finding and treatment, and health
promotion services. In rural Haiti, the "four pillars"
approach to HIV prevention and care introduced by Part-
ners in Health radically increased overall patient visits at
the Las-Cahobas primary health clinic between July 2002
and December 2003, resulting in greatly increased tuber-
culosis case-finding: within 14 months of initiation, over
200 TB patients were identified and began receiving
directly observed therapy (DOT). Prenatal care visits and
immunizations saw similar increases over the same
period, going from 100 visits per day to over 500 for both
services [18,19]. In Zambia, the PMTCT health post
funded by the Global Fund is based in the Reproductive
Health Division, which is leading the incorporation of
PMTCT into routine maternal health services. In Kenya,
the PMTCT strategy and its implementation are integrated
with existing reproductive services [33]. In Rwanda, basic
HIV care has been added into the primary health centers,
contributing to increased use of maternal and reproduc-
tive health, prenatal, pediatric, and general health care
[28].
Basic health infrastructures have also benefited signifi-
cantly from the scaling up of responses to HIV. The Brazil-
ian AIDS program has established a specific network of
units for the provision of care, often by strengthening
existing ones with additional resources [34]. In Lusikisiki,
a village in South Africa, there have been significant
improvements in terms of reliable electricity, water sup-
ply, and telephone and fax services for the clinics. Build-
ing and renovation have increased the number of clinics
with acceptable nursing services and counseling space
[35]. In Haiti, Ethiopia, Malawi, and many other coun-
tries, programs provide funds for the construction of
health posts, renovation of existing facilities at health
centers and hospitals, and training of health personnel
[20-24]. In Cambodia, various disease-control programs,
including HIV/AIDS, TB, and malaria programs, have
been integrated to optimize services and outputs at the
district hospital level. The construction and rehabilitation
of the district hospitals' common laboratories have been
supported. Meanwhile, links and referrals among HIV,
maternal and child health (MCH), and reproductive
health services have been strengthened, with the expecta-
tion that this will improve coverage of PMTCT, MCH, and
reproductive health in general [36].
In most cases, scaled-up programs for HIV/AIDS have pro-
moted the public-private partnership needed to provide
essential services to target populations, which has
enhanced the overall service-delivery capacity of the coun-
tries' health systems. In Ethiopia, private labs perform
CD4 counts and other HIV/AIDS tests under a quota spec-
ified by the Ministry of Health (MOH), and are reim-
bursed for tests conducted [20]. In Malawi, increased
resources support a newly mobilized private nonprofit
sector to implement HIV/AIDS activities focused on pre-
vention, care, and support [22]. Recently, PEPFAR and
Becton, Dickinson and Company (BD) announced their
intention to support the improvement of overall labora-
tory systems and services in African countries severely
affected by HIV/AIDS and TB [37]. In Tanzania, Abbott, a
multinational pharmaceutical company, has funded a
state-of-the-art outpatient treatment center and clinical
labs at Muhimbili National Hospital, which each day will
benefit up to 1,000 people with HIV/AIDS and also
patients with other chronic diseases [38].
However, there is also evidence of possible negative
impacts: in Malawi, the availability of antenatal care serv-
ices and referrals has decreased, most likely due to pro-
vider shortages [22]. There are also concerns that family
planning and reproductive health services have been
increasingly strained in many places by the decreases andGlobalization and Health 2008, 4:8 http://www.globalizationandhealth.com/content/4/1/8
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shifts in donor funding away from reproductive health
and into HIV programs, unless specifically mandated by
donors or national health systems as a needed part of HIV
care [8].
Have health-sector human resources been expanded?
The scaling up of the response to HIV/AIDS has brought
considerable pressure and mixed effects to the health
work force in most countries. However, HIV/AIDS treat-
ment per se also has direct beneficial effects on the health
work force by keeping HIV-infected medical personnel
alive to do their jobs. For example, in Malawi, access to
ART had saved the lives of at least 250 out of 1,022 health
care workers after 12 months of treatment – workers who
were continuing to provide much-needed health services
[39].
Increased awareness of the severe health-worker shortage
that the need to roll out ART and HIV services helped gen-
erate has also led to welcome actions to remedy this prob-
lem. For example, in Kenya, the government has agreed
that the Clinton Foundation, the Global Fund, and PEP-
FAR will fund the salaries of more than 2,000 additional
health workers for a limited period, after which the gov-
ernment will take over [33]. In Zambia, the UK's Depart-
ment for International Development (DFID) supports the
government's retention scheme aimed at ensuring that
health workers are paid additional incentives to work in
the most remote areas [40]. Many countries with substan-
tial scale-up programs, such as Thailand, Brazil, Ghana,
Ethiopia, and Malawi, have started rapidly training com-
munity-level health workers while also gradually expand-
ing the production of higher-level professionals. Malawi
has taken a wider approach, focusing on 11 priority cadres
because of the extreme nature of its crisis [41]. In Ethiopia,
the government decided to hire an additional 30,000
health extension workers in order to place two each in
every rural village; 16,000 have already been trained and
are providing preventive services and basic curative care at
health posts close to their communities [28,40]. The Ethi-
opian government is also rapidly training and adding
nurses and doctors to its health work force. And in Benin,
scaling up the HIV/AIDS program has led to recruitment
of a large body of non-public-sector professionals into the
public sector, which has boosted personnel motivation by
providing training, supplies, and equipment [21]. Both
the morale and the skills of health workers have been
enhanced by means of the training and the incentives
such as salary top-ups associated with delivering HIV/
AIDS-related services in many areas [22].
Innovative models have been created to meet the health
worker shortages resulting from the labor-intensive deliv-
ery requirements of HIV services. WHO, together with
PEPFAR and UNAIDS, recently developed global recom-
mendations and guidelines on task-shifting [42]. In a
recent WHO survey, of 73 low- and middle-income coun-
tries, 28 reported having a policy on task-shifting to allow
reorganization of tasks among health care workers and the
hiring of nonprofessional workers [26]. Research indi-
cates that implementation of task-shifting can reduce the
demand for doctor time by 76 percent. Time freed up can
be used by doctors to manage complex cases, improve the
quality of care, and deliver primary health care [43]. In
Malawi, paramedical officers have been trained to provide
ARV delivery, with impressive results. More than 81,000
people started ARV treatment through the public sector in
Malawi, with only 9 percent of those who begin treatment
failing to return and continue uptake of the ART services
offered [7]. In Haiti, community health workers are mobi-
lized as the cornerstones of the program providing medi-
cal therapy and emotional support to people living with
HIV, and also provide much-needed education on HIV
prevention and health care to the community [44].
However, scaling up the response to HIV/AIDS can tempt
health care workers to take better-paying jobs providing
HIV care, and prompt a disproportionate number to work
in clinical care and laboratories compared to areas like
pharmaceutical support and health education. In Zambia,
there are anecdotal reports of localized brain-drains of
public-sector health professionals who have switched to
well-funded NGO HIV programs. In Rwanda, doctors in
the NGO sector reportedly receive six times the salary of
their public-sector counterparts [33]. As a result, doctors
and nurses move into AIDS care to receive better compen-
sation [8]. In Ethiopia, the health worker situation wors-
ened due to excessive workloads posed by the HIV
programs and the lack of incentive mechanisms for retain-
ing staff [20], until salaries were increased recently.
Has the health information system been strengthened?
There is a common need to strengthen the generation and
use of the information/data required to manage services
and to produce and account for results. Evidence is lim-
ited on the effects of HIV/AIDS programs on the overall
health information system. More and more countries
have been reporting on progress toward the Declaration
of Commitment that was unanimously adopted in the
2001 UN General Assembly Special Session (UNGASS) on
HIV and AIDS: 103 out of 189 countries in 2003; 115 out
of 189 countries in 2005; and 147 out of 192 countries as
of March 2008 [45]. In Malawi, an electronic patient-
monitoring system has been established to replace the
manual paper-based system, improving the information
management capacity of staff [46]. Sharing of information
among different stakeholders has been observed in Benin
[21]. In some countries, information sharing among gov-
ernment and civil society organizations has increased, andGlobalization and Health 2008, 4:8 http://www.globalizationandhealth.com/content/4/1/8
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health information is more available in the public
domain [47].
However, it has been reported that countries that have
made the effort to implement a single national monitor-
ing system remain burdened by duplicative reporting
processes and monitoring missions from multiple pro-
grams [47]. Recognizing this, governments and donors are
trying to work out strategies for improved coordination of
monitoring and information requirements [40]. How-
ever, if harmonization is in progress, there is long way to
go [47,48].
Have procurement and supply management been strengthened?
A functioning procurement and supply management sys-
tem is necessary to achieve equitable access to essential
medicines and technologies. Logistics and supply systems
have been improved as a result of investments in HIV/
AIDS and other disease-control programs in some coun-
tries. In Malawi, national drug procurement now uses the
procurement and distribution system from an earlier, par-
allel procurement system for the disease-control program
[22]. In Rwanda and Burkina Faso, HIV drug procure-
ments supported by donor-driven programs have been
integrated into the national supply system for essential
drugs. In a recent WHO survey, among 66 low- and mid-
dle-income countries reporting data on stock-outs of ARV
drugs, 41 countries had no ARV drug stock-out in 2007.
The remaining 25 countries reported one or more epi-
sodes of stock-out of antiretroviral drugs. Globally, 18
percent of all reporting treatment sites experienced at least
one stock-out of ARV drugs in 2007 [26], which is much
better than the situation of supplying other essential drugs
[Perriëns, personal communication].
The establishment of parallel procurement systems for
HIV/AIDS programs, similar to ones used to procure other
pharmaceuticals and commodities in the public sector,
could have negative impact. When such parallel systems
bypass government structures and directly interfere with
international suppliers, the opportunity to help build the
capacity of the country's own procurement and supply
management system is missed [21]. In Ethiopia, the MOH
outsourced the purchase of drugs and medical supplies
from international markets to UNICEF [20]. In many
countries, separate supply systems exist for ARV drugs and
other commodities funded by the Global Fund and PEP-
FAR, including those for PMTCT, while drugs for essential
obstetric care, contraceptives, and drugs for opportunistic
infections and sexually transmitted infections, imported
through the government system, are subject to frequent
stock-outs [33].
Has health financing been improved?
The global scaling up of the response to HIV/AIDS has
brought vast resources to bear in the fight against HIV/
AIDS. By the end of 2007, AIDS funding was expected to
stand at just under US$ 10 billion – an almost fortyfold
increase compared to 1996, when it was US$ 260 million
[49]. In 2006, it was estimated that US$ 2.5 billion was
spent for AIDS by governments using their own public
funds. The expenditures by low-income Sub-Saharan Afri-
can governments for AIDS were estimated between US$
242.2 million and US$ 390.3 million [50].
While AIDS funding increased, donor support for other
public health programs, such as infectious diseases con-
trol, has also been increasing in low- and lower-income
countries, with one possible exception – population
reproductive health, which in absolute constant dollar
terms stayed relatively stagnant from 1992 to 2005
(approximately the same amount in 1992, US$ 890 mil-
lion, as in 2005, US$ 887 million) [51].
In 25 lower-income Sub-Saharan African countries, the
domestic public-health spending more than doubled in
per capita terms, from US$ 0.31 in 2001 to US$ 0.65 in
2005 [50]. In addition, several GHIs with a focus on AIDS
invested a significant amount in health-system-strength-
ening activities. It is estimated that nearly US$ 640 mil-
lion of PEPFAR funding was directed towards system-
strengthening activities in 2007, including pre-service and
in-service training of health workers [28]. Global Fund
financing has been used for a wide range of strategies to
support health systems, such as salary support and other
means of retaining skilled professionals, and it has
expanded its support for health system strengthening in
the ongoing Global Fund applications [20,52].
However, this picture likely glosses over problems in the
allocation of funding for overall health development in
developing countries, especially the funding for PHC. For
example, total health spending remains critically low in
the African region, averaging US$ 32 per capita in 2000.
This comprised, on average, US$ 12.5 in government
expenditure, US$ 1.2 in donor funds to government, and
US$ 16.8 in private expenditure, which included out-of-
pocket sources [53,54]. Because few resources have been
allocated to PHC, most countries' national health systems
are suffering from absolute inadequacy of financial
resources [53]. Limited absorptive capacity in some coun-
tries is also a concern. Donor funding for HIV/AIDS was
comparable to or exceeded the amounts allocated by the
national government to the entire health sector in some
countries [51]. At the national level, when fiscal ceilings
affect the health budget, as in Uganda and Zambia, there
is the risk that funds earmarked for HIV and other com-
municable diseases will crowd out government alloca-Globalization and Health 2008, 4:8 http://www.globalizationandhealth.com/content/4/1/8
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tions to priorities such as maternal health, to the payroll,
and to infrastructure development for health [33]. Dis-
placement also affects what other donors decide to do
with their funds. For example, in Benin, a few partners/
donors have canceled or reduced their financial contribu-
tions to the subrecipients of GFATM grants because of the
Global Fund contributions [21].
At individual level, user fees are the main barriers to
adherence to ART [55]. Some informal charges such as
transportation and other out-of-pocket expenditures can
present a significant barrier to people gaining full access to
HIV/AIDS treatment and care services. Quite often, the
free ARV package does not cover diagnostics, formal or
informal fees, transport to and from the health service,
and so forth, which are strong risk factor for mortality [56]
Have leadership and governance for health been improved?
Central to all national health systems is the need for effec-
tive leadership and governance. The increase in global
advocacy for scaling up the response to HIV/AIDS and
other major diseases has catalyzed stronger political
awareness and leadership for health, in government and
in civil society. NGOs and PLWHA are now often included
in the decision-making processes through a number of
coordinating mechanisms, such as the Country Coordi-
nating Mechanism (CCM) of the Global Fund [47,57].
Together with scaled-up responses, especially in terms of
treatment for HIV/AIDS, smarter policies have been initi-
ated that target populations previously neglected in many
countries, such as drug users, sex workers, and men who
have sex with men (MSM). Planning, transparency of
management, monitoring and evaluation, and technical
assistance from external sources have been strengthened
[47]. AIDS "treatment activism" has promoted access to
basic medicines, including ARV drugs for the underserved,
and has reduced health care inequities [58].
AIDS activists increasingly advocate for the right of access
to universal primary health care. They have also changed
the dynamics between health care providers and clients,
thus helping prepare health systems for the delivery of
chronic care, which requires much more give-and-take
between care providers and their clients than does the
delivery of acute care [58]. Indeed, it is the activism for
AIDS that has created solidarity about health as a concern
for humanity, and as part of the evolving paradigm on
globalization [59].
In countries like Ethiopia, GHIs supporting the scaling-up
programs are in alignment with the national priorities and
strategies of the countries [20]. The scaled-up response to
HIV/AIDS supported by GHIs has similarly brought
changes to policies and strategies even in countries with
stronger health systems – for example, by increasing polit-
ical commitment and by supporting NGO involvement in
Central Asian and Eastern European countries and in
China, where NGO roles had previously been more polit-
ically constrained and limited [23,24]. Kyrgyzstan
received and is implementing a GFATM grant for HIV/
AIDS services/activities provided primarily by NGOs,
focusing on preventive interventions among high-risk
groups such as injecting drug users (IDUs), prisoners, sex-
workers, and young people. Similar GFATM awards in
China have contributed to opening up the political space
for NGO participation in the CCM process and for services
for marginalized populations such as drug users, sex
workers, and MSM [60]. The World Bank programs also
supported NGOs to deliver interventions in 2007 in Kyr-
gizstan [24]. And GFATM grants helped shape the direc-
tion of policy by funding HIV harm-reduction efforts for
drug users and sex workers in China [47].
However, some observers see PEPFAR's position on absti-
nence and increased reliance on faith-based agencies as
promoting conservative moral and religious views
[61,62]. On governance of the health aid structure, there
is considerable room to improve the harmonization and
coordination among donors and partners at the global,
national, district, and facility levels. Uncoordinated pro-
liferation of foreign aid contributes to fragmentation of
the health systems of many poor countries [63]. For exam-
ple, there are at least four committees focused on HIV/
AIDS in Tanzania – although there is a clear division of
labor [47]. Furthermore, communication between donors
and countries is often a one-way street, and the feedback
loop from countries is weak. In one survey, 350 stake-
holders in 20 countries raised the problem of communi-
cation when working with donors [64].
Discussion
Although accounts of positive and negative effects of AIDS
funding are readily asserted [65,66], available evidence on
the effects of the scaled-up response to HIV/AIDS on
health systems is slim. Many arguments suggesting
impacts of HIV investments on health systems are based
on anecdotes and speculation, on small pilots, or on early
stages of the programs that cannot yet be generalized, and
a number of systematic impact studies are still underway.
Therefore, it would be imprudent to draw any firm con-
clusions at this stage.
However, it is likely that global scale-up of responses to
HIV/AIDS is having a positive effect on many dimensions
of health system performance, especially service delivery
and infrastructure upgrading, and that the majority of
concerns center on human resources. It is therefore
encouraging that major donors and global initiatives are
increasingly acknowledging that they must assume
responsibility for the health system effects of their actions.Globalization and Health 2008, 4:8 http://www.globalizationandhealth.com/content/4/1/8
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Indeed, they are adopting measures to further strengthen
health systems while targeting their focused diseases. The
World Bank has traditionally focused on strengthening
health systems as one of its priorities [63], and now the
GFATM is following suit. The GFATM's Sixteenth Board
Meeting decided to expand support for health-system-
strengthening efforts in coming rounds [28]. PEPFAR is to
channel more resources for training and retaining more
health workers in the countries hardest hit by HIV/AIDS
[29]. And new Global Health Initiatives, such as the Inter-
national Health Partnerships (IHP), explicitly aim to sup-
port building up the health systems of some of the poorest
countries [40]. Then, what should we do next?
Maintain the momentum brought about by investment in 
HIV/AIDS
It is clear that most countries are far from reaching a level
that could conceivably be considered as close to universal
access for HIV/AIDS prevention, treatment and care [26].
Donors and country governments should maintain the
momentum of the movement that enabled interventions
against AIDS to take off in developing countries, and con-
tinue to increase investment in HIV/AIDS. The targets of
universal access to HIV/AIDS prevention, treatment, and
care cannot be reached without increased international
investments in many developing countries.
Maximize the positive synergies of HIV/AIDS programs and 
health system strengthening
It is time now that we move from the current situation of
unplanned "spill-overs" to a more systematic and active
management of the synergies between HIV/AIDS pro-
grams and health system strengthening in countries [67].
This requires concerted efforts for a policy and technical
framework, which will guide actions to avoid threats and
maximize the synergies between HIV/AIDS investment
and health systems.
Strengthen HIV/AIDS service delivery and integrate it into 
the primary health care system
The scaled-up global response to HIV/AIDS began as an
emergency response to the crises of high infection and
death rates and the urgent need for prevention and treat-
ment efforts. However, in the long run, effective preven-
tion, treatment, and care for HIV/AIDS should be
integrated with the existing health service and system
because AIDS is a chronic disease. WHO has proposed a
public health approach to ART to enable scaled-up access
to treatment for HIV-positive people in developing coun-
tries, which entails standardized, simplified treatment
protocols and decentralized service delivery [68]. Increas-
ingly, the evidence is that this approach works – as long as
the health system is strong enough to carry the increased
workload of delivering the HIV services. Consequently, we
have an historic opportunity to start equipping the pri-
mary health care systems in developing countries – which
are currently oriented to maternal and child health and
the care of acute, episodic illnesses – with the skills to
address the chronic health problems that are an emerging
threat there. Together with lifelong care for HIV/AIDS, the
persisting infectious diseases and emerging noncommu-
nicable diseases in many developing countries mean that
their health systems must prepare to become client-per-
spective-based systems oriented towards both acute ill-
ness and chronic care [69-71].
Advocate for increasing funding for universal primary 
health care
Primary health care (PHC), as promoted by the Declara-
tion of Alma-Ata thirty years ago, is key to providing good
value for money and to enhancing equity of health [70].
There are strong movements to revive and renew PHC as
an approach to promote more equitable health and
human development [54]. However, the majority of
developing countries cannot fund PHC with domestic
resources alone. Development partners should therefore
assume more responsibility in supporting countries' PHC,
in addition to funding treatment and care for HIV, TB, and
malaria. It should be recognized that global action for
health is even more underfunded than is the response to
the HIV epidemic. As stated by the Director General of
WHO, sustained commitment is especially important for
a disease like HIV/AIDS, where patient survival depends
on lifelong access to drugs, but it is also important for
funding broader issues such as health system strengthen-
ing [72]. New funds are needed for universal primary
health care, and we must stop arguing about the sharing
of HIV/AIDS funding. The balance needed could be
funded with a modest increase in donor funds and sus-
tained effort in developing countries to meet the Abuja
target of 15% of government expenditure on health [73].
Activists and NGOs should advocate for both causes –
scaled-up response to HIV and strengthening of PHC.
Better document the impact on health systems of 
investment in HIV/AIDS programs
More systematic studies should be undertaken on the
health systems of different countries, using agreed-upon
frameworks and measurements. With partners in PEPFAR
and GFATM, WHO is working on the basic principles and
framework to guide the future design and implementa-
tion of research into this matter. Global health partners
should promote both a rigorous appraisal of experiences
and a frank dialogue on what has been shown to work and
not work in different settings.
Summary
Current scaled-up responses to HIV/AIDS must be main-
tained and strengthened. Instead of endless debate about
the comparative advantages of vertical and horizontalGlobalization and Health 2008, 4:8 http://www.globalizationandhealth.com/content/4/1/8
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approaches, partners should focus on the best ways for
investments in response to HIV to also broadly strengthen
the health system. The evidence is mixed – mostly positive
but some negative – as to the impact on health systems of
the scaled-up responses to HIV/AIDS driven primarily by
global health partnerships. Efforts by countries and their
development partners should continue both (1) to maxi-
mize the positive synergies of investment in HIV/AIDS
and other priority health programs, and (2) to increase
funding for universal primary health care, based on the
principles and modalities of the Paris Declaration on
AIDS Effectiveness – namely, national ownership, align-
ment, and harmonization [74,75].
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